A biotechnology company has begun using Apple Watch devices as part of a clinical trial studying a drug treatment for Parkinson's disease. The integration represents a growing trend of incorporating consumer health technology into pharmaceutical research.
The use of wearable devices in clinical trials allows researchers to collect continuous, real-world data on patient symptoms and responses outside of traditional clinical settings. This approach could provide more comprehensive insights into how treatments affect patients during their daily activities.